
(AGENPARL) – SILVER SPRING mer 29 marzo 2023 The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription.
Fonte/Source: http://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray